The American Renal Associates Holdings Inc.’s Lock-Up Period Will End on October 18th (NYSE:ARA)

The American Renal Associates Holdings Inc.’s Lock-Up Period Will End  on October 18th (NYSE:ARA)

American Renal Associates Holdings’ (NYSE:ARA) lock-up period will end on Tuesday, October 18th. American Renal Associates Holdings had issued 7,500,000 shares in its initial public offering on April 21st. The total size of the offering was $165,000,000 based on an initial share price of $22.00. After the expiration of the company’s lock-up period, company insiders and major shareholders will be able to sell their shares of the company.

Several brokerages have recently weighed in on ARA. Zacks Investment Research raised shares of American Renal Associates Holdings from a “hold” rating to a “buy” rating and set a $29.00 price target for the company in a research report on Monday, July 18th. SunTrust Banks Inc. set a $24.00 price target on shares of American Renal Associates Holdings and gave the stock a “buy” rating in a research report on Thursday. Wells Fargo & Co. reaffirmed a “buy” rating on shares of American Renal Associates Holdings in a research report on Sunday, September 25th. Bank of America Corp. reaffirmed a “buy” rating and issued a $35.00 price target on shares of American Renal Associates Holdings in a research report on Monday, August 22nd. Finally, Leerink Swann reaffirmed a “buy” rating on shares of American Renal Associates Holdings in a research report on Thursday, August 11th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and five have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $29.50.

Shares of American Renal Associates Holdings (NYSE:ARA) opened at 18.02 on Friday. The company’s 50-day moving average is $19.28 and its 200-day moving average is $24.28. The stock’s market cap is $556.24 million. American Renal Associates Holdings has a 52-week low of $17.43 and a 52-week high of $29.65.

American Renal Associates Holdings (NYSE:ARA) last released its quarterly earnings data on Tuesday, August 9th. The company reported ($0.75) earnings per share (EPS) for the quarter. The company had revenue of $185.60 million for the quarter, compared to analysts’ expectations of $161.50 million. Equities analysts anticipate that American Renal Associates Holdings will post $0.95 EPS for the current year.

A number of large investors have recently added to or reduced their stakes in the company. Acrospire Investment Management LLC bought a new stake in shares of American Renal Associates Holdings during the second quarter worth $130,000. American International Group Inc. bought a new stake in shares of American Renal Associates Holdings during the second quarter worth $146,000. Nationwide Fund Advisors bought a new stake in shares of American Renal Associates Holdings during the second quarter worth $166,000. Rhumbline Advisers bought a new stake in shares of American Renal Associates Holdings during the second quarter worth $225,000. Finally, Alambic Investment Management L.P. bought a new stake in shares of American Renal Associates Holdings during the second quarter worth $229,000. Hedge funds and other institutional investors own 85.20% of the company’s stock.

American Renal Associates Holdings Company Profile

Related posts

Leave a Comment